United States Securities and Exchange Commission · EDGAR Accession 0001994911-26-000005

Form C-AR

Annual Report — Regulation Crowdfunding
Campaign file 020-33659
Issuer CIK 1994911
Period 2025-12-31

Rejuve Biotech Inc.

CorporationCAIncorporated 2022ORANGE, CArejuve.bio
B

Financial Condition

two fiscal years, as filed
Pre-revenueBurn increasing6 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(57,800)(13,513)▼ burn
Total assets136,092257,811▼ 47%
Cash & equivalents136,092257,811▼ 47%
Accounts receivable00
Short-term debt00
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer.

C

Campaign Timeline

file 020-33659 · all filings under this campaign
Loading campaign history…